Pangea Biomed

About:

Pangea Biomed combines ML and RNA sequencing to offer personalized cancer treatment.

Website: https://pangeabiomed.com/

Top Investors: NFX, Danny Tocatly

Description:

Pangea Biomed combines ML and RNA sequencing to offer personalized cancer treatment. The company's ENLIGHT platform can surface relevant biological insights to pinpoint the best path forward in combating a patient's cancer by combining the hidden power of RNA sequencing with ML-enabled network effects. It examines the molecular context in which targeted therapies operate, looking beyond actionable genomic abnormalities. Pangea's goal is to democratize precision oncology, bringing deep tumor intelligence to drug development and to treatment nomination for patients.